Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Trial Profile

Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary)
  • Indications Gastroenteritis; Rotavirus infections
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 17 Oct 2016 Results of a post-hoc analysis were published in the Pediatric Infectious Disease Journal
    • 06 Aug 2010 Results in children from Africa published in Lancet.
    • 06 Aug 2010 Results in children from Asia published in Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top